Catalyst Wire Dossier Catalyst Wire Dossier

Setipiprant

setipiprant · Idorsia Pharmaceuticals Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Setipiprant, covering 2018-07-10 to 2019-04-05. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males [Phase 2]

See pricing